If a patient has metastatic triple negative breast cancer, the usual first line of therapy is chemotherapy. There are different chemotherapy options depending on the burden of disease, which refers to how sick someone is with their disease. Triple negative breast cancer is usually responsive to chemotherapy.
In certain instances, a patient will become resistant to their first line of therapy and will have to switch to another chemotherapy. There are many different chemotherapies that are used for triple negative breast cancer. There are also different clinical trials that may be available.
Read More